Breakthrough T1D, formerly known as the Juvenile Diabetes Research Foundation (JDRF), is the leading global organization funding type 1 diabetes (T1D) research. Its mission is to accelerate life-changing breakthroughs to cure, prevent and treat T1D and its complications. To accomplish this, Breakthrough T1D has invested nearly $2 billion in research funding since our inception. Breakthrough T1D is an organization built on a grassroots model of people connecting in their local communities, collaborating regionally for efficiency and broader fundraising impact, and uniting on a national stage to pool resources, passion, and energy. Breakthrough T1D collaborates with academic institutions, policymakers, and corporate and industry partners to develop and deliver a pipeline of innovative therapies to people living with T1D. The Breakthrough T1D  staff and volunteers in more than 100 locations throughout the United States and our six international affiliates are dedicated to advocacy, community engagement and our vision of a world without T1D. For more information, please visit breakthrought1d.org. 

Type 1 diabetes (T1D) is an autoimmune disease in which a person’s pancreas stops producing insulin, a hormone people need to get energy from food. T1D strikes both children and adults, and its onset has nothing to do with diet or lifestyle. There is currently nothing you can do to prevent it, and there is no cure.

• T1D is an autoimmune disease wherein the immune system attacks the insulin-producing cells in the pancreas

• T1D has nothing to do with diet or lifestyle

• There is nothing you can do to prevent T1D…and nothing you can do to get rid of it

• T1D strikes children and adults suddenly, and at any age

• People with T1D must inject or infuse insulin to survive but insulin is not a cure

• Complications of T1D include kidney failure, blindness, nerve damage, heart attack and stroke

• 1.25M Americans are living with T1D and 40,000 are diagnosed each year

• By 2050, it is estimated that 5M people in the US will have T1D

• T1D-associated healthcare costs total $14B each year

• T1D is associated with an estimated loss of life expectancy of up to 13 years

The Epsilon Psi Chapter of Delta Tau Delta proudly supports Breakthrough T1D, the organization dedicated to funding research and advancing treatments for Type 1 Diabetes. Students, parents, and alumni can support our fundraising goals by attending chapter philanthropy events, making direct donations to our fundraising campaigns, sponsoring events, or helping spread awareness within their networks. Alumni and families can also support by partnering with the chapter to provide sponsorships, auction items, or matching gifts through their employers. Every contribution—whether through participation, advocacy, or financial support—helps our chapter continue its commitment to making a meaningful impact in the fight against Type 1 Diabetes.